Literature DB >> 22766224

Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.

Khalil J Diab1, Zhangsheng Yu, Karen L Wood, James A Shmalo, Francis D Sheski, Mark O Farber, David S Wilkes, Robert P Nelson.   

Abstract

Nonmyeloablative conditioning before allogeneic hematopoietic cell transplant (HCT) is an alternative to conventional conditioning in older patients and those with comorbidities. It is not known whether the decreased tissue injury associated with nonmyeloablative conditioning lowers the risk of pulmonary complications. The medical records of patients who underwent transplantation were reviewed and all pulmonary complications documented. Sixty-two consecutive patients with hematologic malignancies who underwent minimally intensive HCT (subjects) were compared to 48 consecutive patients who received conventional myeloablative allogeneic peripheral blood HCT (controls) over the same period at Indiana University Hospital. Pulmonary complications were categorized according to the type of complication and the time of onset after transplantation. Median follow-up times were similar between groups (P = .70). The study population (minimal intensity recipients) was older (P < .01), and the incidence of chronic graft-versus-host disease (cGVHD) was higher in subjects than controls (P = .02). Sixty-nine percent of subjects and 73% of controls developed pulmonary complications (P = .70). There was a trend in the minimally conditioned patients towards a lower incidence of pulmonary complications in older patients in the early posttransplantation period and a higher incidence of infectious pneumonias and bronchiolitis obliterans syndrome at later time points. The frequency of pulmonary complications seems to be similar after minimally intensive or myeloablative conditioning and allotransplantation. There was no difference in overall mortality or pulmonary-related mortality between the 2 groups.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22766224     DOI: 10.1016/j.bbmt.2012.06.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  11 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

Authors:  L Platon; L Amigues; P Ceballos; N Fegueux; D Daubin; N Besnard; R Larcher; L Landreau; C Agostini; S Machado; O Jonquet; K Klouche
Journal:  Bone Marrow Transplant       Date:  2015-11-16       Impact factor: 5.483

3.  Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Bianca Harris; Sejal M Morjaria; Eric R Littmann; Alexander I Geyer; Diane E Stover; Juliet N Barker; Sergio A Giralt; Ying Taur; Eric G Pamer
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

4.  Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Authors:  Lee Gazourian; Laura Spring; Emily Meserve; David Hwang; Alejandro A Diaz; Samuel Y Ash; Vincent T Ho; Lynette M Sholl; George R Washko
Journal:  Biol Blood Marrow Transplant       Date:  2017-06-28       Impact factor: 5.742

Review 5.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

6.  Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study.

Authors:  Yuhua Qu; Xu Yang; Xiaohong Zhang; Shanshan Liu; Xiaoping Liu; Xiaodan Liu; Ailing Luo; Mansi Cai; Yaping Yan; Ling Xu; Hua Jiang
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

7.  Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Guang-Shing Cheng; Angela P Campbell; Hu Xie; Zach Stednick; Cheryl Callais; Wendy M Leisenring; Janet A Englund; Jason W Chien; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-31       Impact factor: 5.742

8.  Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Lee Gazourian; Angela J Rogers; Ruby Ibanga; Gerald L Weinhouse; Victor Pinto-Plata; Jerome Ritz; Robert J Soiffer; Joseph H Antin; George R Washko; Rebecca M Baron; Vincent T Ho
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

9.  [The function of NLRP1 in noninfectious pulmonary injury following allogeneic hematopoietic stem cell transplantation].

Authors:  M F Li; W Li; L Ding; Y L Wu; L Liu; W Ju; J L Qiao; K L Xu; L Y Zeng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

10.  Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy.

Authors:  Guang-Shing Cheng; Zach J Stednick; David K Madtes; Michael Boeckh; George B McDonald; Steven A Pergam
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-31       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.